Chylomicrons prevent endotoxin toxicity and increase endotoxin uptake
by hepatocytes. As a consequence, less endotoxin is available to activ
ate macrophages, thereby reducing tumor necrosis factor secretion. To
determine whether the chylomicron-mediated increase in hepatocellular
uptake of endotoxin results in increased endotoxin excretion into bile
, we examined bile after endotoxin administration. A sublethal dose (7
mug/kg) of I-125-endotoxin was incubated with either rat mesenteric l
ymph containing nascent chylomicrons (500 mg of chylomicron triglyceri
de per kg of body weight) or an equal volume of normal saline (control
s) for 3 h and then infused into male Sprague-Dawley rats. Bile sample
s were collected via a common bile duct catheter for 24 h. Infusion of
endotoxin incubated with chylomicrons increased biliary excretion of
endotoxin by 67% at 3 h (P less-than-or-equal-to 0.006) and by 20% at
24 h (P less-than-or-equal-to 0.01) compared with infusion of endotoxi
n incubated in saline. Endotoxin activity, as measured by the Limulus
assay, was not detected in the bile of test animals. However, endotoxi
n activity was detected after hot phenol-water extraction of bile, dem
onstrating that endotoxin is inactive in the presence of bile but reta
ins bioactivity after hepatic processing. Since the majority of an int
ravenous endotoxin load has been shown to be cleared by the liver, acc
eleration of hepatocyte clearance and biliary excretion of endotoxin m
ay represent a component of the mechanism by which chylomicrons protec
t against endotoxin-induced lethality.